Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.61 |
| ▸ | CES2 | O00748 | 1/20 | 0.53 |
| ▸ | CES1 | P23141 | 1/20 | 0.53 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | EDNRA | P25101 | 2/20 | 0.47 |
| ▸ | EDNRB | P24530 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anisole SCHEMBL7562607 | 1.00 | CA4 (0.61) | CA4CES2CES1LTA4HCA1 | |
| Anisole SCHEMBL28177334 | 1.00 | CA4 (0.61) | CA4CES2CES1LTA4HCA1 | |
| Anisole SCHEMBL28145757 | 1.00 | CA4 (0.61) | CA4CES2CES1LTA4HCA1 | |
| Anisole SCHEMBL2335694 | 0.92 | CA4 (0.52) | CA4CES2CES1LTA4HPPARG | |
| Anisole SCHEMBL28945470 | 0.91 | CA4 (0.50) | CA4CES2CES1LTA4HPPARG | |
| Anisole SCHEMBL7204405 | 0.91 | CA4 (0.50) | CA4CES2CES1LTA4HCA1 | |
| 1,3-Dimethoxybenzene SCHEMBL11452224 | 0.88 | LMNA (0.58) | CES2CES1SMN1; SMN2 | |
| Anisole SCHEMBL7444295 | 0.88 | CA4 (0.47) | CA4CES2CES1LTA4HCA1 | |
| Trifluoroacetic Acid SCHEMBL27892361 | 0.87 | RAB9A (0.50) | CES2CES1ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL27598900 | 0.87 | RAB9A (0.50) | CES2CES1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7459550-B2 | Process for the preparation of Cefditoren | ORCHID CHEMICALS & PHARMACEUTICALS LTD. (IN) | 2008-12-02 | — | — | US | claimed |
| EP-1562957-B1 | PROCESS FOR THE PREPARATION OF 3-PROPENYL CEPHALOSPORIN DMF SOLVATE | ORCHID CHEMICALS & PHARM LTD (IN) | 2006-09-13 | — | — | EP | claimed |
| US-20060173175-A1 | Process for the preparation of cefditoren | ORCHID CHEMICALS & PHARMACEUTICALS LTD. (IN) | 2006-08-03 | — | — | US | claimed |
| EP-1562957-A1 | PROCESS FOR THE PREPARATION OF 3-PROPENYL CEPHALOSPORIN DMF SOLVATE | Orchid Chemicals and Pharmaceuticals Ltd (IN) | 2005-08-17 | — | — | EP | claimed |
| US-6903211-B2 | Process for the preparation of 3-propenyl cephalosporin DMF solvate | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2005-06-07 | — | — | US | claimed |
| EP-1501839-A2 | PROCESS FOR THE PREPARATION OF CEFTIOFUR ACID | Orchid Chemicals & Pharmaceuticals Ltd. (IN) | 2005-02-02 | — | — | EP | claimed |
| WO-2005003141-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF CEFDITOREN | ORCHID CHEMICALS & PHARMACEUTICALS LTD (IN) | 2005-01-13 | — | — | WO | claimed |
| US-6800756-B2 | CONDENSATION; CYCLIZATION | ORCHID CHEMICALS AND PHARMACEUTICALS, LTD. (IN) | 2004-10-05 | — | — | US | claimed |
| WO-2004083216-A1 | A PROCESS FOR THE PREPARATION OF CEPHALOSPORINS | ORCHID CHEMICALS & PHARMACEUTICALS LTD (IN) | 2004-09-30 | — | — | WO | claimed |
| US-20040132995-A1 | Process for the preparation of cephalosporins | ORCHID CHEMICALS & PHARMACEUTICALS, LTD. (IN) | 2004-07-08 | — | — | US | claimed |
| WO-2004039812-A1 | PROCESS FOR THE PREPARATION OF 3-PROPENYL CEPHALOSPORIN DMF SOLVATE | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2004-05-13 | — | — | WO | claimed |
| US-20040087786-A1 | Process for the preparation of 3-propenyl cephalosporin DMF solvate | ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) | 2004-05-06 | — | — | US | claimed |
| US-20030216567-A1 | New method for the preparation of ceftiofur sodium and its intermediates | ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED (IN) | 2003-11-20 | — | — | US | claimed |
| WO-2003093278-A2 | PROCESS FOR THE PREPARATION OF CEFTIOFUR ACID | ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED (IN) | 2003-11-13 | — | — | WO | claimed |
| JP-8245632-A | — | — | None | — | — | JP | disclosed |
| EP-3689892-B1 | RADIOACTIVE DRUG | UNIV CHIBA NAT UNIV CORP (JP) | 2024-07-17 | — | — | EP | disclosed |
| EP-3997520-B1 | RINSE AND METHOD OF USE THEREOF FOR REMOVING EDGE PROTECTION LAYERS AND RESIDUAL METAL HARDMASK COMPONENTS | MERCK PATENT GMBH (DE) | 2023-12-20 | — | — | EP | disclosed |
| US-3966719-A | ANTIBACTERIAL | PFIZER INC. (US) | 1976-06-29 | — | — | US | disclosed |
| US-3946001-A | BACTERICIDES | E. R. SQUIBB & SONS, INC. (US) | 1976-03-23 | — | — | US | disclosed |
| US-3931170-A | BACTERICIDE | E. R. SQUIBB & SONS, INC. (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040087786-A1 | Process for the preparation of 3-propenyl cephalosporin DMF solvate | CYP2F1, PEF1, CYP4Z1 | CA4 2046/4885CES2 912/4885CES1 365/4885 |
| US-20030216567-A1 | New method for the preparation of ceftiofur sodium and its intermediates | BLVRB, CBR1, DCXR | CA4 340/4885CES2 438/4885CES1 1237/4885 |
| US-20060173175-A1 | Process for the preparation of cefditoren | DHPS, FDPS, CYP4F2 | CA4 1233/4885CES2 176/4885CES1 298/4885 |
| US-20040132995-A1 | Process for the preparation of cephalosporins | CYP2F1, CYP7A1, MRPL21 | CA4 1577/4885CES2 323/4885CES1 46/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.